Composition of Innate Lymphoid Cell Subsets in the Human Skin: Enrichment of NCR(+) ILC3 in Lesional Skin and Blood of Psoriasis Patients

Overview

Journal J Invest Dermatol

Publisher Elsevier

Specialty Dermatology

Date 2014 Mar 25

PMID 24658504

Citations 144

Authors

Marcel B M Teunissen

J Marius Munneke

Jochem H Bernink

Phyllis I Spuls

Pieter C M Res

Anje Te Velde

Stanley Cheuk

Marijke W D Brouwer

Stef P Menting

Liv Eidsmo

Hergen Spits

Mette D Hazenberg

Jenny Mjosberg

Affiliations

Soon will be listed here.

Abstract

Innate lymphoid cells (ILCs) are increasingly appreciated as important regulators of tissue homeostasis and inflammation. However, their role in human skin remains obscure. We found that healthy peripheral blood CD117(+) ILC3, lacking the natural cytotoxicity receptor (NCR) NKp44 (NCR(-) ILC3), CD117(-)NCR(-)CRTH2(-)CD161(+) ILC1, and CRTH2(+) ILC2, express the skin-homing receptor cutaneous lymphocyte antigen (CLA). NCR(+) ILC3 were scarce in peripheral blood. Consistently, we identified in normal skin ILC2 and NCR(-) ILC3, a small proportion of CD161(+) ILC1, and hardly any NCR(+) ILC3, whereas NCR(+) ILC3 were present in cultured dermal explants. The skin ILC2 and NCR(+) ILC3 subsets produced IL-13 and IL-22, respectively, upon cytokine stimulation. Remarkably, dermal NCR(-) ILC3 converted to NCR(+) ILC3 upon culture in IL-1β plus IL-23, cytokines known to be involved in psoriatic inflammation. In line with this observation, significantly increased proportions of NCR(+) ILC3 were present in lesional skin and peripheral blood of psoriasis patients as compared with skin and blood of healthy individuals, respectively, whereas the proportions of ILC2 and CD161(+) ILC1 remained unchanged. NCR(+) ILC3 from skin and blood of psoriasis patients produced IL-22, which is regarded as a key driver of epidermal thickening, suggesting that NCR(+) ILC3 may participate in psoriasis pathology.

Citing Articles

T-betILC3 in peripheral blood is increased in the ankylosing spondylitis with high disease activity.

Liu Y, Shen Y, Ding H, He D, Cheng P, Wu X Heliyon. 2025; 11(1):e41678.

PMID: 39866450 PMC: 11757778. DOI: 10.1016/j.heliyon.2025.e41678.

Interleukin-17 Inhibitors in the Treatment of Hidradenitis Suppurativa.

Pinto Salgueiro G, Yilmaz O, Nogueira M, Torres T BioDrugs. 2024; 39(1):53-74.

PMID: 39604776 PMC: 11750882. DOI: 10.1007/s40259-024-00687-w.

OLFM4 modulates intestinal inflammation by promoting IL-22ILC3 in the gut.

Xing Z, Li X, He J, Chen Y, Zhu L, Zhang X Commun Biol. 2024; 7(1):914.

PMID: 39075283 PMC: 11286877. DOI: 10.1038/s42003-024-06601-y.

Autoimmune Diseases and Plasma Cells Dyscrasias: Pathogenetic, Molecular and Prognostic Correlations.

Giordano L, Cacciola R, Barone P, Vecchio V, Nasso M, Alvaro M Diagnostics (Basel). 2024; 14(11).

PMID: 38893662 PMC: 11171610. DOI: 10.3390/diagnostics14111135.

Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis.

Pertiwi K, Teunissen M, Krebbers G, Willems M, Huisman L, Poelen C Front Immunol. 2024; 15:1354617.

PMID: 38638438 PMC: 11024276. DOI: 10.3389/fimmu.2024.1354617.

References

Neill D, Wong S, Bellosi A, Flynn R, Daly M, Langford T . Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010; 464(7293):1367-70. PMC: 2862165. DOI: 10.1038/nature08900. View

Mjosberg J, Trifari S, Crellin N, Peters C, Van Drunen C, Piet B . Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011; 12(11):1055-62. DOI: 10.1038/ni.2104. View

Spits H, Artis D, Colonna M, Diefenbach A, Di Santo J, Eberl G . Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol. 2013; 13(2):145-9. DOI: 10.1038/nri3365. View

Pantelyushin S, Haak S, Ingold B, Kulig P, Heppner F, Navarini A . Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. J Clin Invest. 2012; 122(6):2252-6. PMC: 3366412. DOI: 10.1172/JCI61862. View

Mjosberg J, Bernink J, Golebski K, Karrich J, Peters C, Blom B . The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity. 2012; 37(4):649-59. DOI: 10.1016/j.immuni.2012.08.015. View

Monticelli L, Sonnenberg G, Abt M, Alenghat T, Ziegler C, Doering T . Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol. 2011; 12(11):1045-54. PMC: 3320042. DOI: 10.1031/ni.2131. View

Crellin N, Trifari S, Kaplan C, Cupedo T, Spits H . Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J Exp Med. 2010; 207(2):281-90. PMC: 2822607. DOI: 10.1084/jem.20091509. View

Piskin G, Sylva-Steenland R, Bos J, Teunissen M . In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol. 2006; 176(3):1908-15. DOI: 10.4049/jimmunol.176.3.1908. View

Satoh-Takayama N, Vosshenrich C, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F . Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity. 2008; 29(6):958-70. DOI: 10.1016/j.immuni.2008.11.001. View

10.

Cupedo T, Crellin N, Papazian N, Rombouts E, Weijer K, Grogan J . Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol. 2008; 10(1):66-74. DOI: 10.1038/ni.1668. View

11.

Nestle F, Kaplan D, Barker J . Psoriasis. N Engl J Med. 2009; 361(5):496-509. DOI: 10.1056/NEJMra0804595. View

12.

Bernink J, Peters C, Munneke M, Te Velde A, Meijer S, Weijer K . Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol. 2013; 14(3):221-9. DOI: 10.1038/ni.2534. View

13.

Spits H, Di Santo J . The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2010; 12(1):21-7. DOI: 10.1038/ni.1962. View

14.

Basu R, OQuinn D, Silberger D, Schoeb T, Fouser L, Ouyang W . Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity. 2012; 37(6):1061-75. PMC: 3678257. DOI: 10.1016/j.immuni.2012.08.024. View

15.

Walker J, Barlow J, McKenzie A . Innate lymphoid cells--how did we miss them?. Nat Rev Immunol. 2013; 13(2):75-87. DOI: 10.1038/nri3349. View

16.

Nakajima K . Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis. J Dermatol. 2012; 39(3):219-24. DOI: 10.1111/j.1346-8138.2011.01458.x. View

17.

Villanova F, Flutter B, Tosi I, Grys K, Sreeneebus H, Perera G . Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol. 2013; 134(4):984-991. PMC: 3961476. DOI: 10.1038/jid.2013.477. View

18.

Spits H, Cupedo T . Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu Rev Immunol. 2012; 30:647-75. DOI: 10.1146/annurev-immunol-020711-075053. View

19.

Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H . Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2009; 463(7280):540-4. DOI: 10.1038/nature08636. View

20.

Kim B, Siracusa M, Saenz S, Noti M, Monticelli L, Sonnenberg G . TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med. 2013; 5(170):170ra16. PMC: 3637661. DOI: 10.1126/scitranslmed.3005374. View